SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-24-000225
Filing Date
2024-01-04
Accepted
2024-01-04 16:07:48
Documents
2
Period of Report
2024-01-03

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 4515
2 STEVEN PAUL POA 2019 stevepaulpoa2019.txt EX-24 2133
  Complete submission text file 0001562180-24-000225.txt   8080
Mailing Address C/O ELI LITTY & CO LIIY CORPORATE CENTER DC 1093 INDIANAPOLIS IN 46285
Business Address
PAUL STEVEN M (Reporting) CIK: 0001237564 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36544 | Film No.: 24511878

Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Issuer) CIK: 0001597553 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)